UNSPSC 51171650: Lactitol monohydrate

This classification denotes an artificial sweetener C12H24O11.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UH2K6W1Y64, chemically known as d-glucitol, 4-o-.beta.-d-galactopyranosyl-, monohydrate, but more generally known as lactitol monohydrate, which bears US NIH Compound Identifier 3067270. European Medicines Agency schedules Lactitol monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12097MIG.

Most nations, for tariff and trade purposes, schedule lactitol monohydrate under HS 29400000 and SITC 51692. As of Q4 2014, LACTITOL MONOHYDRATE remains US FDA's Preferred Term for this commodity. Lactitol monohydrate bears US NLM identifiers UMLS ID C2697878 and NCI Concept Code C77137. SMILES: C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O.O.

UNSPSC 51171650 Lactitol monohydrate is a Commodity code with little demonstrated alignment to recent state and local procurement activity. The three most recent opportunities tagged to this code involve offender drug testing services, pharmaceutical benefit program strategy, and generic multi-source pharmaceutical distribution — none of which center on lactitol monohydrate as a procured input. State and local governments do source specialty chemicals and pharmaceutical ingredients, but the recent solicitations indexed under this code do not reflect demand for lactitol monohydrate specifically. The issuing bodies in the recent pipeline — Collin County Community Supervision and Corrections Department, Texas Health and Human Services Commission, and Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) — are procuring finished testing services, conducting market research on prescription fulfillment, and acquiring branded and generic pharmaceuticals through authorized wholesalers, respectively, rather than sourcing raw pharmaceutical excipients.

Geographic activity appears concentrated in Texas and Minnesota based on the recent opportunities, but the code's relevance to lactitol monohydrate procurement remains unclear. The most concrete recent opportunity is Collin County's RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026 — but this solicitation addresses laboratory screening and confirmation methodology, staffing, and result reporting, not chemical supplies. MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, involves finished pharmaceutical products distributed through authorized wholesalers, also disconnected from lactitol monohydrate sourcing. Unless state and local governments are procuring lactitol monohydrate as a bulk input for in-house pharmaceutical compounding or formulation — a use case not evident in recent opportunities — this code shows minimal relevant procurement activity in the current market.